Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Liver metastases
Liver metastases are commonly detected in a range of malignancies including colorectal
cancer (CRC), pancreatic cancer, melanoma, lung cancer and breast cancer, although CRC …
cancer (CRC), pancreatic cancer, melanoma, lung cancer and breast cancer, although CRC …
Gastroenteropancreatic neuroendocrine tumors
J Strosberg - The American Cancer Society's Oncology in …, 2018 - Wiley Online Library
Neuroendocrine tumors (NETs) are heterogeneous neoplasms that vary considerably based
on primary site, differentiation, and grade. A minority of NETs are characterized by the ability …
on primary site, differentiation, and grade. A minority of NETs are characterized by the ability …
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival …
Background The primary analysis of the phase 3 NETTER-1 trial showed significant
improvement in progression-free survival with 177 Lu-Dotatate plus long-acting octreotide …
improvement in progression-free survival with 177 Lu-Dotatate plus long-acting octreotide …
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
B Kos‐Kudła, JP Castaño, T Denecke… - Journal of …, 2023 - Wiley Online Library
This ENETS guidance paper for well‐differentiated nonfunctioning pancreatic
neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working …
neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working …
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes
This ENETS guidance paper aims to provide practical advice to clinicians for the diagnosis,
treatment and follow‐up of functioning syndromes in pancreatic neuroendocrine tumours …
treatment and follow‐up of functioning syndromes in pancreatic neuroendocrine tumours …
[177Lu] Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well …
S Singh, D Halperin, S Myrehaug, K Herrmann… - The lancet, 2024 - thelancet.com
Background There are currently no standard first-line treatment options for patients with
higher grade 2–3, well-differentiated, advanced, gastroenteropancreatic neuroendocrine …
higher grade 2–3, well-differentiated, advanced, gastroenteropancreatic neuroendocrine …
The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors
JR Howe, NB Merchant, C Conrad, XM Keutgen… - Pancreas, 2020 - journals.lww.com
This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the surgical management of pancreatic neuroendocrine tumors …
consensus conference on the surgical management of pancreatic neuroendocrine tumors …
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis
T Ito, T Masui, I Komoto, R Doi, RY Osamura… - Journal of …, 2021 - Springer
Neuroendocrine neoplasms (NENs) are rare neoplasms that occur in various organs and
present with diverse clinical manifestations. Pathological classification is important in the …
present with diverse clinical manifestations. Pathological classification is important in the …
The North American neuroendocrine tumor society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors
This article is the result of the North American Neuroendocrine Tumor Society consensus
conference on the medical management of pancreatic neuroendocrine tumors from July 19 …
conference on the medical management of pancreatic neuroendocrine tumors from July 19 …
The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets
Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically and
genetically heterogeneous malignancies, characterized by distinct prognoses based upon …
genetically heterogeneous malignancies, characterized by distinct prognoses based upon …